Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

BACKGROUND: Bleeding is the most common complication of oral anticoagulants, due to inadequate dosing. CASE PRESENTATION: This report describes the clinical course of a patient who developed severe bleeding under therapy with phenprocoumon, despite an INR in the lower therapeutic range. Strikingly,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mülling, Nils, Rosery, Vivian, Reinhardt, H. Christian, Hanoun, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243751/
https://www.ncbi.nlm.nih.gov/pubmed/34187575
http://dx.doi.org/10.1186/s40001-021-00533-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243751/
https://www.ncbi.nlm.nih.gov/pubmed/34187575
http://dx.doi.org/10.1186/s40001-021-00533-7

Ejemplares similares